This inventor holds 1 USPTO granted patent. Top assignee: Cangene Corporation. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Eva Walcyzk: Innovator in Protease Research
Introduction
Eva Walcyzk is a notable inventor based in Mississauga, Canada. She has made significant contributions to the field of protease research, particularly through her innovative work with Streptomyces. Her research has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Eva Walcyzk holds a patent for "Streptomyces proteases and improved streptomyces strains for expression." This patent describes a family of proteases that are endogenous to Streptomyces cells, which degrade heterologous proteins secreted from Streptomyces host cells. The patent identifies previously unidentified proteases, including tripeptidyl aminopeptidase-Streptomyces ('Tap') and a Streptomyces protease ('Ssp') that shows significant amino acid sequence homology to Subtilisin BPN'. These proteases have the ability to remove tripeptides from the amino termini of proteins and peptides. The research also discusses methods to alleviate degradation by selective inhibition of secreted proteases or by using hosts with impaired capabilities to produce proteases.
Career Highlights
Eva is currently associated with Cangene Corporation, where she continues her research and development in protease technology. Her work has led to advancements in understanding the mechanisms of protease action and the development of irreversible inhibitors based on the specificity of target proteases.
Collaborations
Eva has collaborated with notable colleagues, including Dany Hadary and Lawrence T Malek. These collaborations have enriched her research and contributed to the advancement of protease studies.
Conclusion
Eva Walcyzk's innovative work in the field of proteases highlights her role as a significant contributor to biotechnology. Her patent and ongoing research continue to pave the way for advancements in this important area.